Company: CYTK
Filing Date: 2025-02-27
Form Type: S-3ASR
Source: 0001193125-25-039426
Chunk: 15

Company: CYTOKINETICS INC
Filing Date: 2025-02-27
Form: S-3ASR
Chunk 15
---
 non-assessable. Preferred Stock Pursuant to our certificate of incorporation, our board of directors has the authority, without further approval by our stockholders, to designate and issue up to 10,000,000 shares of preferred stock in one or more series. Our board of directors previously designated 8,070 of the authorized shares of preferred stock as Series A convertible preferred stock, and 23,026 of the authorized shares of preferred stock as Series B convertible preferred stock, none of which are currently outstanding. Our board of directors may designate the powers, preferences and rights, and the qualifications, limitations or restrictions of each series of preferred stock, including dividend rights, dividend rate, conversion rights, voting rights, rights and terms of redemption (including sinking fund provisions), redemption price or prices, and liquidation preferences, any or all of which may be greater than the rights of the common stock. Thus, without stockholder approval, our board of directors could authorize the issuance of preferred stock with voting, conversion and other rights that could dilute the voting power and other rights of holders of our common stock, and may have the effect of decreasing the market price of the common stock. The description of certain provisions of the preferred stock set forth in any prospectus supplement does not purport to be complete and is subject to and qualified in its entirety by reference to our certificate of incorporation and the certificate of designations relating to each series of preferred stock. The applicable prospectus supplement (and any related free writing prospectus that we may authorize to be provided to you) will describe the specific terms of any series of preferred stock being offered which may include:

| • |     | the specific designation, number of shares, seniority and purchase price; |

| • |     | any liquidation preference per share and any accumulated dividends upon the liquidation, dissolution or winding 
 up of our affairs;                                                                                              |

| • |     | any redemption, repayment or sinking fund provisions; |

9

| • |     | any dividend rate or rates, whether dividend rate is fixed or variable, the date dividends accrue, the dates on                                       
 which any those dividends will be payable (or the method by which those rates or dates will be determined), and whether dividends will be cumulative; |

| • |     | any voting rights; |

| • |     | if other than the currency of the United States, the currency or currencies (including composite currencies) in 
 which the preferred stock is denominated and in which payments will or may be payable;